Drug intelligence / Profile preview

enflurane

Development stage
Unknown
Lead developer
Ohio Medical Products
Modality
Small Molecules
Administration
Inhalation
01

Overview

Enflurane is a halogenated inhalational anesthetic agent used for the induction and maintenance of general anesthesia and for analgesia during labor and delivery. It was developed by Ross Terrell in 1963 and first used clinically in 1966. Enflurane is a clear, colorless liquid with a mild, sweet odor. Induction of and recovery from anesthesia with enflurane are rapid. Its mechanism of action involves positive allosteric modulation of GABAA and glycine receptors, leading to central nervous system depressant effects; it also acts on calcium channels in the cardiac sarcoplasmic reticulum causing cardiodepressant effects. Enflurane can lower the seizure threshold and has been associated with increased risk of seizures compared to other inhaled anesthetics[1][2][7]. It has largely been replaced by newer agents but was previously widely used for surgical anesthesia.

Brand names
EthraneEnflurane
Other names
enflurane
02

Targets

RYR2 (Ryanodine receptor 2)GluR (Glutamate receptors)GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)Glycine receptor

Beyond the preview

Go deeper on enflurane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on enflurane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call